Medical Xpress
NOVEMBER 10, 2022
In recent years, genetically re-engineered immune cells—armed with molecular weaponry to recognize and destroy tumor cells—have changed the landscape of cancer treatment.
Medical Xpress
APRIL 4, 2025
Collaborative research led by investigators at Dana-Farber/Boston Children's Cancer and Blood Disorders Center defines a novel approach to understanding how certain proteins called transcription factors determine which genetic programs will drive cell growth and maturation. The study is published in the journal Science.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Medical Futurist
JUNE 21, 2025
The 80-year-old Ray Flynn lost his central vision entirely, but with the help of the retinal implant, he could make out shapes on the computer screen. However, things are moving fast, and success doesn’t come easy for the pioneers of any medical field. Running trials in animals will take additional engineering and safety tests.
The Physicians Foundation
FEBRUARY 14, 2025
Misplaced Training Dollars: Lack of funding for community-based training impacting the primary care physician pipeline Hospital-based graduate medical education (GME) receives significantly more funding than community-based programs, a disparity linked to fewer new primary care physicians entering the workforce. In 2022, only 24.4%
Imperial Center Family Medicine
MAY 5, 2025
It’s similar to revving a car engine for too long while staying still. No matter if it’s through medication, therapy, lifestyle changes, or often a combination, managing depression can translate to measurable heart health gains. However, chronic stress keeps your body in a continuous state of high alert.
Permanente Medicine
MAY 20, 2025
Khang Nguyen, MD, chief transformation officer of the Southern California Permanente Medical Group, discusses how AI can increase clinicians’ joy in medicine and improve patient outcomes with Chris Grant, chief operating offer and executive vice president of Kaiser Permanente, The Permanente Federation, and host of the Permanente Medicine Podcast.
FDA Law Blog
DECEMBER 6, 2023
FDA tries to justify the proposed rule by claiming that LDTs present significant risks, and that the solution is to regulate them all as medical devices. Tests such as genetic testing of prospective parents, prenatal screening, cancer prognosis, and testing for rare diseases play a critical role in the health care system.
Expert insights. Personalized for you.
131 
Let's personalize your content